Disciplined Growth Investors Inc Surmodics Inc Transaction History

Disciplined Growth Investors Inc

  • $4.73 Billion
  • Q3 2024

A detailed history of Disciplined Growth Investors Inc transactions in Surmodics Inc stock. As of the latest transaction made, Disciplined Growth Investors Inc holds 276,876 shares of SRDX stock, worth $11.1 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
276,876
Previous 580,566 52.31%
Holding current value
$11.1 Million
Previous $24.4 Million 56.01%
% of portfolio
0.23%
Previous 0.47%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$38.47 - $42.24 $11.7 Million - $12.8 Million
-303,690 Reduced 52.31%
276,876 $10.7 Million
Q2 2024

Aug 15, 2024
SELL
$25.39 - $42.1 $2 Million - $3.31 Million
-78,609 Reduced 11.93%
580,566 $24.4 Million
Q1 2024

May 15, 2024
BUY
$27.44 - $35.56 $1.22 Million - $1.57 Million
44,284 Added 7.2%
659,175 $19.3 Million
Q4 2023

Feb 14, 2024
BUY
$28.47 - $38.49 $546,282 - $738,546
19,188 Added 3.22%
614,891 $22.4 Million
Q3 2023

Nov 14, 2023
BUY
$28.28 - $38.36 $5.33 Million - $7.24 Million
188,623 Added 46.34%
595,703 $19.1 Million
Q2 2023

Aug 14, 2023
BUY
$17.67 - $31.31 $36,912 - $65,406
2,089 Added 0.52%
407,080 $12.7 Million
Q1 2023

May 15, 2023
SELL
$17.13 - $38.52 $68,382 - $153,771
-3,992 Reduced 0.98%
404,991 $9.23 Million
Q4 2022

Feb 14, 2023
BUY
$29.44 - $37.31 $32,707 - $41,451
1,111 Added 0.27%
408,983 $14 Million
Q3 2022

Nov 15, 2022
BUY
$28.84 - $38.92 $9,603 - $12,960
333 Added 0.08%
407,872 $12.4 Million
Q2 2022

Aug 15, 2022
BUY
$33.25 - $45.11 $34,480 - $46,779
1,037 Added 0.26%
407,539 $15.2 Million
Q1 2022

May 16, 2022
BUY
$40.68 - $49.72 $265,355 - $324,323
6,523 Added 1.63%
406,502 $18.4 Million
Q4 2021

Feb 14, 2022
SELL
$43.21 - $57.6 $306,272 - $408,268
-7,088 Reduced 1.74%
399,979 $19.3 Million
Q2 2021

Aug 16, 2021
BUY
$51.29 - $59.15 $4.14 Million - $4.77 Million
80,655 Added 24.71%
407,067 $22.1 Million
Q1 2021

May 17, 2021
BUY
$42.18 - $56.07 $7.77 Million - $10.3 Million
184,117 Added 129.39%
326,412 $18.3 Million
Q4 2020

Feb 16, 2021
SELL
$35.18 - $43.52 $302,583 - $374,315
-8,601 Reduced 5.7%
142,295 $6.19 Million
Q3 2020

Nov 16, 2020
SELL
$37.98 - $48.72 $41,246 - $52,909
-1,086 Reduced 0.71%
150,896 $5.87 Million
Q2 2020

Aug 14, 2020
SELL
$31.07 - $44.74 $139,752 - $201,240
-4,498 Reduced 2.87%
151,982 $6.57 Million
Q1 2020

May 15, 2020
SELL
$22.46 - $42.24 $439,295 - $826,172
-19,559 Reduced 11.11%
156,480 $5.21 Million
Q4 2019

Feb 14, 2020
BUY
$39.01 - $47.51 $25,551 - $31,119
655 Added 0.37%
176,039 $7.29 Million
Q3 2019

Nov 15, 2019
BUY
$38.66 - $47.41 $19,059 - $23,373
493 Added 0.28%
175,384 $8.02 Million
Q2 2019

Aug 14, 2019
BUY
$38.23 - $47.43 $20,300 - $25,185
531 Added 0.3%
174,891 $7.55 Million
Q1 2019

May 14, 2019
BUY
$41.26 - $58.35 $98,075 - $138,697
2,377 Added 1.38%
174,360 $7.58 Million
Q4 2018

Feb 13, 2019
SELL
$44.93 - $73.38 $80,110 - $130,836
-1,783 Reduced 1.03%
171,983 $8.13 Million
Q3 2018

Nov 16, 2018
SELL
$56.85 - $80.35 $204,944 - $289,661
-3,605 Reduced 2.03%
173,766 $13 Million
Q2 2018

Aug 15, 2018
SELL
$35.85 - $57.05 $13,156 - $20,937
-367 Reduced 0.21%
177,371 $9.79 Million
Q1 2018

May 17, 2018
SELL
$27.0 - $38.5 $30,132 - $42,966
-1,116 Reduced 0.62%
177,738 $6.76 Million
Q4 2017

Feb 15, 2018
SELL
$28.0 - $33.2 $61,628 - $73,073
-2,201 Reduced 1.22%
178,854 $5.01 Million
Q3 2017

Nov 14, 2017
BUY
$24.5 - $31.1 $4.44 Million - $5.63 Million
181,055
181,055 $5.61 Million

Others Institutions Holding SRDX

# of Institutions
127
Shares Held
11.8M
Call Options Held
1.4K
Put Options Held
8.6K
View Full List

About SURMODICS INC

SRDX Quotes by TradingView
  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $559M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Disciplined Growth Investors Inc Portfolio

Follow Disciplined Growth Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email